Treating Patients With Melanoma and ALK Alterations With Ensartinib
Clinical trial NCT03420508 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03420508
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-10
- Primary completion
- 2027-01-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.